[Efficacy of Different Regimens and Prognostic Factors in Patients with First Relapsed Multiple Myeloma Treated after Front-Line Bortezomib, Cyclophosphamide, and Dexamethasone].
Zhonghua nei ke za zhi（2023）
Key words
Multiple myeloma,Recurrence,Prognosis,Immune therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined